Hem › Bröstcancer › Texas › Austin
Kliniska studier för Bröstcancer i Austin, TX
18 studier för Bröstcancer söker deltagare vid platser i och runt Austin (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekryterarFas 1/2
- New Experimental Therapeutics - NEXT Oncology, Austin
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
RekryterarFas 1
- Next Oncology Austin, Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekryterarFas 1
- NEXT Oncology - Austin, Austin
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
RekryterarFas 1/2
- Texas Oncology, Austin
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekryterarFas 3
- Texas Oncology Central/South, Austin
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
RekryterarFas 1
- NEXT Austin, Austin
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekryterarFas 2/3
- Texas Oncology - Central/South Texas, Austin
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekryterarFas 3
- Texas Oncology - Austin, Austin
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekryterarFas 1/2
- Texas Oncology - Central / South Texas, Austin
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
RekryterarFas 1/2
- Texas Oncology - Central/South, Austin
Cancer Pain Management Using a Web-based Intervention
Rekryterar
- The University of Texas at Austin, Austin
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekryterarFas 3
- Texas Oncology - Central South (Balcones Dr), Austin
- Texas Oncology - Central South (James Casey), Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RekryterarFas 1
- NEXT Oncology Austin, Austin
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekryterarObservationsstudieFriska volontärer välkomna
- Elligo Health Research, Inc., Austin
Sample Collection for Ongoing Research and Product Evaluation Study
RekryterarObservationsstudie
- Natera, Inc., Austin
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RekryterarFas 1
- Exelixis Clinical Site #4, Austin
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekryterarObservationsstudie
- Texas Oncology - Austin, Austin
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
RekryterarFas 2
- Texas Oncology PA (Austin), Austin
Bröstcancer-studier i andra städer
- New York City, NY134 studier
- Houston, TX126 studier
- Boston, MA111 studier
- Nashville, TN80 studier
- Los Angeles, CA72 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Durham, NC63 studier
- Queens, NY63 studier
- Chicago, IL58 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andra studier i Austin
- Icke-småcellig lungcancer30 studier
- Cancer (alla typer)20 studier
- Övervikt20 studier
- Metastaserande cancer19 studier
- Kolorektal cancer19 studier
- Hjärtsvikt18 studier
- Övervikt18 studier
- Äggstockscancer17 studier
- Endometriecancer15 studier
- Prostatacancer15 studier
- Depression14 studier
- Triplenegativ bröstcancer13 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.